A Study of the Safety, Tolerability and Efficacy of Treatment With AP1189 in Early RA Patients With Active Joint Disease
Clinical trial NCT04004429 · COMPLETED
Trial details
- NCT number
- NCT04004429
- Sponsor
- SynAct Pharma Aps
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2021-11-16
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.